Overweight and Obese Volunteers.

2

Review clinical trials related to Overweight and Obese Volunteers.. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluate LAE102 in Healthy and Overweight/Obese Subjects

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.

Participants needed: 160
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Laekna LimitedUpdated: Jan 9, 2026Locations: 1
Eligibility criteria

Male or female and aged 18 to 65 years (inclusive) at the screening visit [+6]

With clinically significant abnormalities in vital signs, physical examination,... [+20]

Status: Recruiting

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

To investigate the safety and tolerability after single and multiple ascending doses of MDR-001 Tablets administered orally in healthy participants and obese/ overweight participants.

Participants needed: 131
Trial details
Phase: Phase 1, Phase 2Age: 18-55Biological sex: AllType: InterventionalSponsor: MindRank AI LtdUpdated: Mar 7, 2025Locations: 1
Eligibility criteria

Participants who are aged ≥ 18 and ≤ 55 years at the time of signing the informe... [+2]

Participants with any condition that increases the risk of bleeding, such as hem... [+11]